153 related articles for article (PubMed ID: 17364475)
41. Low affinity PEGylated hemoglobin from Trematomus bernacchii, a model for hemoglobin-based blood substitutes.
Coppola D; Bruno S; Ronda L; Viappiani C; Abbruzzetti S; di Prisco G; Verde C; Mozzarelli A
BMC Biochem; 2011 Dec; 12():66. PubMed ID: 22185675
[TBL] [Abstract][Full Text] [Related]
42. Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration.
Gao JQ; Eto Y; Yoshioka Y; Sekiguchi F; Kurachi S; Morishige T; Yao X; Watanabe H; Asavatanabodee R; Sakurai F; Mizuguchi H; Okada Y; Mukai Y; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
J Control Release; 2007 Sep; 122(1):102-10. PubMed ID: 17628160
[TBL] [Abstract][Full Text] [Related]
43. Thiolytically cleavable dithiobenzyl urethane-linked polymer-protein conjugates as macromolecular prodrugs: reversible PEGylation of proteins.
Zalipsky S; Mullah N; Engbers C; Hutchins MU; Kiwan R
Bioconjug Chem; 2007; 18(6):1869-78. PubMed ID: 17935288
[TBL] [Abstract][Full Text] [Related]
44. Poly(2-dimethylamino ethylmethacrylate)-based polymers to camouflage red blood cell antigens.
Cerda-Cristerna BI; Cottin S; Flebus L; Pozos-Guillén A; Flores H; Heinen E; Jolois O; Gérard C; Maggipinto G; Sevrin C; Grandfils C
Biomacromolecules; 2012 Apr; 13(4):1172-80. PubMed ID: 22416913
[TBL] [Abstract][Full Text] [Related]
45. PEGylation of human serum albumin: reaction of PEG-phenyl-isothiocyanate with protein.
Meng F; Manjula BN; Smith PK; Acharya SA
Bioconjug Chem; 2008 Jul; 19(7):1352-60. PubMed ID: 18572961
[TBL] [Abstract][Full Text] [Related]
46. In vitro refolding of PEGylated lipase.
Kim MY; Kwon JS; Kim HJ; Lee EK
J Biotechnol; 2007 Aug; 131(2):177-9. PubMed ID: 17683821
[TBL] [Abstract][Full Text] [Related]
47. Design of folate-linked liposomal doxorubicin to its antitumor effect in mice.
Yamada A; Taniguchi Y; Kawano K; Honda T; Hattori Y; Maitani Y
Clin Cancer Res; 2008 Dec; 14(24):8161-8. PubMed ID: 19088031
[TBL] [Abstract][Full Text] [Related]
48. Protein PEGylation decreases observed target association rates via a dual blocking mechanism.
Kubetzko S; Sarkar CA; Plückthun A
Mol Pharmacol; 2005 Nov; 68(5):1439-54. PubMed ID: 16099846
[TBL] [Abstract][Full Text] [Related]
49. A new PEG-beta-alanine active derivative for releasable protein conjugation.
Pasut G; Mero A; Caboi F; Scaramuzza S; Sollai L; Veronese FM
Bioconjug Chem; 2008 Dec; 19(12):2427-31. PubMed ID: 19053302
[TBL] [Abstract][Full Text] [Related]
50. Studies on the aggregation behaviour of pegylated human red blood cells with the Zeta sedimentation technique.
Jovtchev S; Stoeff S; Arnold K; Zschörnig O
Clin Hemorheol Microcirc; 2008; 39(1-4):229-33. PubMed ID: 18503130
[TBL] [Abstract][Full Text] [Related]
51. Selective Attachment of Polyethylene Glycol to Hemerythrin for Potential Use in Blood Substitutes.
Arkosi MK; Mot AC; Lupan I; Tegla MGG; Silaghi-Dumitrescu R
Protein J; 2023 Aug; 42(4):374-382. PubMed ID: 37119381
[TBL] [Abstract][Full Text] [Related]
52. Hemospan: design principles for a new class of oxygen therapeutic.
Vandegriff KD; Winslow RM
Artif Organs; 2009 Feb; 33(2):133-8. PubMed ID: 19178457
[TBL] [Abstract][Full Text] [Related]
53. Antibody identification using both automated solid-phase red cell adherence assay and a tube polyethylene glycol antiglobulin method.
Yamada C; Serrano-Rahman L; Vasovic LV; Mohandas K; Uehlinger J
Transfusion; 2008 Aug; 48(8):1693-8. PubMed ID: 18482178
[TBL] [Abstract][Full Text] [Related]
54. Site-specific PEGylation of proteins containing unnatural amino acids.
Deiters A; Cropp TA; Summerer D; Mukherji M; Schultz PG
Bioorg Med Chem Lett; 2004 Dec; 14(23):5743-5. PubMed ID: 15501033
[TBL] [Abstract][Full Text] [Related]
55. GlycoPEGylation of recombinant therapeutic proteins produced in Escherichia coli.
DeFrees S; Wang ZG; Xing R; Scott AE; Wang J; Zopf D; Gouty DL; Sjoberg ER; Panneerselvam K; Brinkman-Van der Linden EC; Bayer RJ; Tarp MA; Clausen H
Glycobiology; 2006 Sep; 16(9):833-43. PubMed ID: 16717104
[TBL] [Abstract][Full Text] [Related]
56. Development of PEGylated adenovirus vector with targeting ligand.
Eto Y; Yoshioka Y; Mukai Y; Okada N; Nakagawa S
Int J Pharm; 2008 Apr; 354(1-2):3-8. PubMed ID: 17904316
[TBL] [Abstract][Full Text] [Related]
57. Increased inter dimeric interaction of oxy hemoglobin is necessary for attenuation of reductive pegylation promoted dissociation of tetramer.
Hu T; Li D; Meng F; Prabhakaran M; Acharya SA
Artif Cells Blood Substit Immobil Biotechnol; 2011 Apr; 39(2):69-78. PubMed ID: 20653337
[TBL] [Abstract][Full Text] [Related]
58. Effects of PEGylated scFv antibodies against Plasmodium vivax duffy binding protein on the biological activity and stability in vitro.
Kim SH; Lee YS; Hwang SY; Bae GW; Nho K; Kang SW; Kwak YG; Moon CS; Han YS; Kim TY; Kho WG
J Microbiol Biotechnol; 2007 Oct; 17(10):1670-4. PubMed ID: 18156783
[TBL] [Abstract][Full Text] [Related]
59. Transglutaminase-mediated PEGylation of proteins: direct identification of the sites of protein modification by mass spectrometry using a novel monodisperse PEG.
Mero A; Spolaore B; Veronese FM; Fontana A
Bioconjug Chem; 2009 Feb; 20(2):384-9. PubMed ID: 19186937
[TBL] [Abstract][Full Text] [Related]
60. Hemoglobin conjugated micelles based on triblock biodegradable polymers as artificial oxygen carriers.
Shi Q; Huang Y; Chen X; Wu M; Sun J; Jing X
Biomaterials; 2009 Oct; 30(28):5077-85. PubMed ID: 19560197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
